Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
D000547:Amantadine / Q000494:pharmacology*; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects*; D003342:Corpus Striatum / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D005260:Female; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism; D009647:Normetanephrine / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D013997:Time Factors; D014439:Tyramine / Q000378:metabolism
D000978:Antiparkinson Agents; D002395:Catecholamines; D011955:Receptors, Drug; D009647:Normetanephrine; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine